Feb 12 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved labeling changes to six menopause hormone therapies to remove references to risks of cardiovascular disease, breast cancer,

“BHA has remained in the food supply for decades despite being identified by the National Toxicology Program as ‘reasonably anticipated to be a human carcinogen’ based on animal studies,” U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr ., said.

Sen. Josh Hawley calls for Congress to crack down on abortion pill mifepristone, citing rising emergency room rates and mounting safety concerns from studies.

Here's what we know.

Vinay Prasad, the FDA's Center for Biologics Evaluation and Research head, is accused of interpersonal impropriety as pushback builds against his decision to reject Moderna’s influenza vaccine candidate.

MORRISVILLE, NC / ACCESS Newswire / February 12, 2026 / Clinical trials are the research studies required to test the

The FDA accepted the supplemental new drug application (sNDA) for aminolevulinic acid hydrochloride 10% topical gel (Ameluz) as part of photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC). 1

A nationwide recall affects hundreds of bags of cake and bread mixes containing undeclared milk that could trigger life-threatening reactions in allergic individuals.